Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;95:922-929
Published online before print October 7, 2004, doi: 10.1161/01.RES.0000147311.54833.03
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
95/9/922    most recent
01.RES.0000147311.54833.03v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Earley, S.
Right arrow Articles by Brayden, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Earley, S.
Right arrow Articles by Brayden, J. E.
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Gene expression
Right arrow Ion channels/membrane transport
(Circulation Research. 2004;95:922.)
© 2004 American Heart Association, Inc.


Cellular Biology

Critical Role for Transient Receptor Potential Channel TRPM4 in Myogenic Constriction of Cerebral Arteries

Scott Earley, Brian J. Waldron, Joseph E. Brayden

From the Department of Pharmacology, University of Vermont College of Medicine, Burlington.

Correspondence to Scott Earley, PhD, Dept of Pharmacology, University of Vermont College of Medicine, 89 Beaumont Ave, Burlington, VT. E-mail Scott.Earley{at}uvm.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Local control of cerebral blood flow is regulated in part through myogenic constriction of resistance arteries. Although this response requires Ca2+ influx via voltage-dependent Ca2+ channels secondary to smooth muscle cell depolarization, the mechanisms responsible for alteration of vascular smooth muscle (VSM) cell membrane potential are not fully understood. A previous study from our laboratory demonstrated a critical role for a member of the transient receptor potential (TRP) superfamily of ion channels, TRPC6, in this response. Several other of the approximately 22 identified TRP proteins are also present in cerebral arteries, but their functions have not been elucidated. Two of these channels, TRPM4 and TRPM5, exhibit biophysical properties that are consistent with a role for control of membrane potential of excitable cells. We hypothesized that TRPM4/TRPM5-dependent currents contribute to myogenic vasoconstriction of cerebral arteries. Cation channels with unitary conductance, ion selectivity and Ca2+-dependence similar to those of cloned TRPM4 and TRPM5 were present in freshly isolated VSM cells. We found that TRPM4 mRNA was detected in both whole cerebral arteries and in isolated VSM cells whereas TRPM5 message was absent from cerebral artery myocytes. We also found that pressure-induced smooth muscle cell depolarization was attenuated in isolated cerebral arteries treated with TRPM4 antisense oligodeoxynucleotides to downregulate channel subunit expression. In agreement with these data, myogenic vasoconstriction of intact cerebral arteries administered TRPM4 antisense was attenuated compared with controls, whereas KCl-induced constriction did not differ between groups. We concluded that activation of TRPM4-dependent currents contributed to myogenic vasoconstriction of cerebral arteries.


Key Words: TRP channels • cerebral circulation • cation channels • vasoconstriction


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Small arteries and arterioles supplying blood to the brain constrict in response to increasing intraluminal pressure and dilate in response to decreasing pressure. This vital regulatory mechanism, known as the vascular myogenic response, ensures that blood flow remains nearly constant during moment-to-moment changes in arterial pressure. Although initially described in vivo,1 myogenic constriction also occurs in blood vessels studied in isolation,2,3 demonstrating that mechanisms inherent to the vascular wall are sufficient to induce this response. Disruption of the endothelium does not impair pressure-induced constriction,4 suggesting that sensor and effector mechanisms responsible for myogenic reactivity both reside at the level of smooth muscle cells. Increased intravascular pressure causes depolarization of the arterial myocyte cell membrane,5 thereby activating voltage-dependent Ca2+ channels, resulting in Ca2+ influx and subsequent vasoconstriction.6 Despite the essential nature of this response, signaling pathways responsible for pressure-induced smooth muscle depolarization are poorly understood. Improved comprehension of this mechanism could have significant therapeutic potential because impaired myogenic responsiveness and cerebral blood flow autoregulation are associated with a number of pathological conditions, including systemic hypertension,7 diabetes mellitus,8 stroke,9 and head trauma.10

Under resting conditions, vascular smooth muscle (VSM) membrane potential is a consequence of ionic homeostasis. Disruption of this equilibrium via activation of mechanosensitive ion channels could account for altered membrane potential during pressure elevation. Consistent with this hypothesis, a previous study from our laboratory11 demonstrated a critical role for the transient receptor potential (TRP) channel TRPC6 in pressure-induced smooth muscle depolarization and vasoconstriction of cerebral arteries. TRPC6 is a member of the TRP superfamily of cation channels, comprising at least 22 separate genes.12 Although message for other TRPs is present in blood vessels,13 potential functions of the majority of these proteins in vascular tissues have not been reported. The current study focused on TRPM4 and TRPM5, members of the melastatin TRP subfamily, which exhibit distinguishing biophysical characteristics suggesting a potential role for regulation of Ca2+ homeostasis of excitable cells.14,15 When expressed in HEK cells, these channels are selective for monovalent cations, Ca2+-impermeant, and are activated by intracellular Ca2+.14,15 Interestingly, the unitary conductance of these two TRPs ({approx}25 pico Siemens [pS]) is similar to that reported for mechanosensitive cation channels expressed by smooth muscle cells.16–19 We, therefore, hypothesized that TRPM4 and/or TRPM5 contribute to VSM cell depolarization and vasoconstriction associated with increases in intraluminal pressure. Here we report the presence of a channel with biophysical properties similar to TRPM4 and TRPM5 in cerebral artery smooth muscle cells. Message for TRPM4 but not TRPM5 was detected in these cells. Consistent with our hypothesis, we found that downregulation of TRPM4 expression in isolated vessels impairs pressure-induced depolarization and vasoconstriction, suggesting a key role for this channel in cerebral blood flow regulation.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cerebral and cerebellar arteries used for these studies were isolated from male Sprague-Dawley rats (250 to 350 g; Charles River Laboratories; St. Constant, Quebec, Canada). All animal use procedures were in accordance with institutional guidelines and approved by the Institutional Animal Care and Use Committee of the University of Vermont. To determine whether TRPM4 or TRPM5 like-channels were present in cerebral artery myocytes, the current-voltage characteristics and Ca2+-dependence of cation channels expressed by these cells were investigated. Inside-out membrane patches were obtained from enzymatically dispersed smooth muscle cells. The bathing solution (intracellular face) contained (in mmol/L) 110 Na-glutamate, 5 NaCl, 10 HEPES (pH 7.2), and 60 mannitol. CaCl2 was added to the bath solution to achieve the concentration required for specific protocols. The pipette solution contained (in mmol/L) 110 NaCl, 10 HEPES (pH 7.4), 1.5 MgCl2, 2 CaCl2, 60 mannitol, and 300 nmol/L iberiotoxin. These solutions result in reversal potentials for Na+{cong}–1 mV, for Cl{cong}–79 mV, and for Ca2+{cong}76 mV (when bath [Ca2+]=100 µmol/L). For some experiments, cells were treated with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) (0.5 µmol/L) for at least 10 minutes before membrane patches were excised. RT-PCR was used to determine whether TRPM4 and TRPM5 mRNA were present in cerebral arteries. Total RNA was extracted from isolated vessels or dispersed smooth muscle cells and first-strand cDNA was synthesized. Forward and reverse primers specific for TRPM4 were as follows: TRPMF, 5'-GTCATCGTGAGCAAGATGATGAA-3'; and TRPM4R, 5'-GTCCACCTTCTGGGACGTGC-3'. These primers yield a 707-bp PCR product. Forward and reverse primers specific for TRPM5 were TRPM5F 5'-CAAGTGTGACATGGTGGCCATC TT-3' and TRPM5R 5'-GCTCAGGTGGCTGAGCAGGAT-3', yielding a 639-bp PCR product. PCR products were resolved on 1% agarose gels.

Antisense oligodeoxynucleotides (ODNs) were used to downregulate TRPM4 expression in isolated cerebral arteries. Sequences of TRPM4 antisense ODNs that were used were as follows: TRPM4 AS-1, 5'-GTGTGCATCGCTGTCCCACA-3'; and TRPM4 AS-2, 5'-CTGCGATAGCACTCGCCAAA-3' (Qiagen, Inc). Complementary sequences were used as sense ODNs. Fluorescein was conjugated to the 5' terminal nucleotides to assess cellular location. ODNs were introduced into intact cerebral arteries using a reversible permeabilization procedure.20 After reversal of permeabilization, arteries were organ-cultured for 2.5 days in DMEM/F-12 medium without serum. Semiquantitative RT-PCR was used to evaluate the effects of antisense ODNs on TRPM4 mRNA levels. Smooth muscle cells isolated from cultured arteries were patch-clamped in the inside-out configuration to investigate the effects of antisense ODNs on the frequency of observation of a TRPM4-like channel. In additional experiments, sense- and antisense-treated arteries were mounted in an arteriograph, endothelial cells were removed, and the effects TRPM4-downregulation on pressure-induced smooth muscle cell depolarization and vasoconstriction were evaluated.

An expanded Materials and Methods section can be found in the online data supplement available at http://circres.ahajournals.org.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
TRPM4-/TRPM5-Like Channel Is Present in Rat Cerebral Arteries
Patch-clamp studies were performed to determine whether channels with biophysical properties similar to TRPM4 and TRPM5 were present in cerebral artery smooth muscle cells. In some inside-out membrane patches obtained from freshly isolated cells (9 of 72 cells; 12.5%; n=10 rats), channels were observed that exhibited inward currents at negative holding potentials, reversed near 0 mV, and became outward at positive holding potentials (Figure 1A; bath [Ca2+]=100 µmol/L). The bath and pipette solutions used for these experiments included symmetrical [Na+], whereas Cl and Ca2+ ions were asymmetrically distributed on either side of the membrane. In this configuration, the linear current-voltage relationship reversed at near 0 mV (Figure 1B), which was consistent with a cation channel conducting Na+ ions. Single channel conductance ({gamma}) calculated from the slope of the I–V curve was {approx}24 pS (Figure 1B). Unlike cloned TRPM4,14 this channel did not appear to be voltage dependent (NPo at –80 mV=0.52±0.16, n=4; and at +80 mV=0.58±0.03, n=3).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1. A, Example single-channel recordings obtained at holding potentials (VH) from +80 mV to –80 mV. Bath [Ca2+]=100 µmol/L; c indicates closed state. B, Unitary current-voltage relationship for control (n=3 to 9 at each holding potential) or PMA-treated (n=3 to 11) cells with symmetrical [Na]+ in bath and pipette solutions. Data for each group were fitted to a linear function. Control, {gamma}=24 pS, Erev=–4.9±1.8 mV; PMA treated, {gamma}=24 pS, Erev=–6.1±2.9 mV. C, Unitary current voltage relationship for PMA-treated cells with 110 mmol/L Na+ in the pipette solution and 100 mmol/L Ca2+ in the bath solution (n=3 at each holding potential). {gamma}=14 pS; Erev=14.0±3.3 mV.

Characterization of this channel was initially protracted because of the low frequency of observation. However, it was recently reported that the PKC activator PMA increases the frequency of observation of a TRPM4-like cation channel from 6.7% to {approx}50% in cardiac myocytes.21 In agreement with these data, we found that pretreatment of VSM cells with PMA before membrane patches were excised increased the frequency of channel observation from 12.5% to 47% (33 of 70 cells; n=12 rats). The current-voltage relationship, single-channel conductance, and NPo at –40 mV (bath [Ca2+]=100 µmol/L) of patches from PMA-treated cells did not differ from those of untreated cells,

Cloned TRPM4 and TRPM5 channels exhibit considerable selectivity for Na+ versus Ca2+ ions. To examine the ionic specificity of the {approx}24 pS present in cerebral arteries, we substituted Ca2+ for Na+ in the bath (intracellular) solution used for inside-out patch-clamp studies. Ca2+ replacement shifted the reversal potential from near 0 mV (Figure 1B) to {approx}+14 mV (Figure 1C). The relative permeability of Ca2+ versus Na+ (PCa/PNa) was estimated using the Fatt-Ginsborg22 equation as 0.09, indicating that this channel is selective for Na+ ions.

Another distinguishing characteristic of TRPM4 and TRPM5 is that both are activated by intracellular [Ca2+]. We, therefore, examined the effects of bath [Ca2+] on NPo of the {approx}24 pS cation channel in excised patches. Channel openings were not observed when intracellular [Ca2+] was 100 nmol/L (n=4). However, channel activity was observed when bath [Ca2+] was ≥1 µmol/L. Channel activity increased with increasing Ca2+ concentration (Figure 2A and 2B), demonstrating Ca2+-dependence of the {approx}24 pS cation channel. [Ca2+] for half-maximal channel activity was {approx}200 µmol/L.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 2. Effects of bath [Ca2+] on channel activity. A, Example single channel recordings at bath [Ca2+] of 0.1, 10, 100, and 1000 µmol/L. VH=–40 mV; c indicates closed state. B, Open probability (NPo) as a function of bath [Ca2+]. n=4 at each concentration. Data were fitted to a Boltzman function.

The Ca2+-dependence, unitary conductance, and ion permeability of this cerebral artery myocyte channel were consistent with those reported for cloned TRPM414,15 and TRPM5.23–26 To determine whether message encoding these channels was expressed by rat cerebral arteries, we performed RT-PCR for TRPM4 and TRPM5. Message for TRPM4 was present in RNA isolated from both whole cerebral arteries as well as smooth muscle cells isolated from these vessels (Figure 3). TRPM5 message was also present in RNA from whole cerebral arteries (Figure 3). However, we found that TRPM5 was absent in RNA extracted from isolated smooth muscle cells (Figure 3). These findings indicate that the {approx}24 pS Ca2+-dependent cation channel identified in cerebral artery myocytes could be TRPM4 but not TRPM5.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. RT-PCR for TRPM4 and TRPM5 for RNA extracted from whole cerebral artery (CA) or isolated smooth muscle cells (SMC). NT indicates no template control.

Downregulation of TRPM4 Expression in Cerebral Arteries
To date, selective inhibitors of TRP channels are not available. Therefore, to investigate a potential functional role for TRPM4 in cerebral arteries we suppressed expression of the channel using antisense technology. We found that the fluorescence of arteries that were permeabilized and exposed to fluorescein-labeled TRPM4 antisense ODNs (Figure 4A) was much greater than that of arteries that were exposed to ODNs but not permeabilized (Figure 4B) or untreated arteries (Figure 4C). Fluorescently labeled ODNs appeared to be present within smooth muscle of permeabilized arteries (Figure 4A), suggesting efficient delivery to these cells.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 4. A through C, Photomicrographs demonstrating entry of fluorescein-labeled ODNs into VSM cells of permeabilized arteries. A, Cerebral artery permeabilized and exposed to fluorescein-labeled ODNs (green). B, Cerebral artery exposed to labeled ODNs but not permeabilized. C, An untreated cerebral artery. Bar=50 µm. D through E, Semiquantitative RT-PCR for arteries treated with TRPM4 sense or antisense ODNs. D, PCR for TRPM4. E, PCR for TRPC6. F through G, Semiquantitative RT-PCR for arteries treated with TRPC6 sense or antisense ODNs. F, PCR for TRPM4. G, PCR for TRPC6. For all experiments, GAPDH PCR was used to demonstrate uniformity of reaction conditions between groups.

Semiquantitative RT-PCR was used to evaluate the effects of antisense ODNs on TRPM4 mRNA levels. We found that the intensity of TRPM4 bands in reactions using cDNA derived from antisense-treated arteries was less than that of sense-treated vessels (Figure 4D), suggesting that antisense ODNs suppress TRPM4 expression. The band intensity of a housekeeping gene (GAPDH) did not differ between groups (Figure 4D). We also examined the effects of TRPM4 antisense on mRNA levels of TRPC6, previously shown to contribute to cerebral artery function.11 Expression of TRPC6 was unaffected by TRPM4 antisense (Figure 4E). As an additional control, we assessed the effects of TRPC6 antisense on TRPM4 mRNA levels in cerebral arteries. TRPM4 expression was not altered by TRPC6 antisense (Figure 4F), whereas TRPC6 mRNA levels were diminished in these arteries (Figure 4G).

To further examine the possibility that the {approx}24 pS channel is TRPM4, we studied the effects of TRPM4 antisense on the frequency of observation of the channel in patch-clamp experiments. Inside-out membrane patches were obtained from smooth muscle cells isolated from TRPM4 sense and antisense treated arteries after PMA administration. Channels ({approx}24 pS) were observed in cells obtained from TRPM4-sense treated arteries at a frequency (53%) similar to that of cells from untreated arteries (47%). In contrast, these channels were less frequently (10%) observed in cells from arteries treated with TRPM4 antisense ODNs (Table). The number of cells exhibiting TRPM4-like channels was significantly less for antisense compared with sense-treated vessels (Table). These findings further support the hypothesis that the {approx}24 pS Ca2+-activated monovalent-selective cation channel expressed by cerebral artery myocytes is TRPM4.


View this table:
[in this window]
[in a new window]
 
Table 1. Frequency of Observation of TRPM4-Like Channels in Cells from Sense- and Antisense-Treated Arteries

Functional Role of TRPM4 in Cerebral Arteries
The effects of TRPM4 downregulation on pressure-induced depolarization and myogenic constriction were examined using isolated, pressurized cerebral blood vessels treated with TRPM4 sense and antisense ODNs. We found that VSM cells in TRPM4-sense treated arteries were more depolarized when the vessels were pressurized at 80 Torr compared with 20 Torr (Figure 5A and 5B). Smooth muscles cells in these vessels were also depolarized when the purinergic receptor agonist UTP (30 µmol/L) was administered. The degree of pressure and agonist-induced depolarization observed in these experiments was consistent with those reported for freshly isolated arteries.6,27 In contrast, smooth muscle membrane potential of antisense-treated arteries did not depolarize when pressure was elevated from 20 or 80 Torr (Figure 5C and 5D). Furthermore, VSM cells in antisense-treated arteries pressurized to 80 Torr were hyperpolarized compared with sense-treated vessels at this pressure (Figure 5D). Administration of UTP (30 µmol/L) induced depolarization of smooth muscle in antisense-treated vessels equal to that in sense-treated arteries (Figure 5D). These findings show that TRPM4 contributes to pressure-, but not UTP-, dependent smooth muscle cell depolarization in cerebral arteries.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. Membrane potential of VSM cells in pressurized cerebral arteries treated with TRPM4 sense (A and B) or antisense (C and D) ODNs. Left, Example traces at intraluminal pressures of 20 and 80 Torr. Right, Mean±SEM. *P<0.05 vs sense ODN-treated arteries at 20 Torr; #P<0.05 vs sense ODN-treated arteries at 80 Torr; **P<0.05 vs antisense-treated arteries at 20 and 80 Torr. n=4 to 6.

In subsequent studies, we found that arterial constriction resulting from administration of 60 mmol/L KCl did not differ between sense and antisense-treated arteries (Figure 6A), suggesting that TRPM4 downregulation does not impair K+ depolarization-induced vasoconstriction of these vessels. However, myogenic constriction of TRPM4 antisense-treated vessels was much less than that of sense-treated arteries (Figure 6B through 6C). Pressure-induced constriction of TRPM4 antisense-treated vessels was significantly (P<0.05) less than that of sense-treated arteries at intraluminal pressures ≥60 Torr. These findings demonstrate an important functional role for TRPM4 in pressure-induced depolarization and constriction of cerebral blood vessels.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 6. A, 60 mmol/L KCl-induced constriction for cerebral arteries treated with TRPM4 sense and antisense ODNs. There was no difference between groups. n=6 for both groups. B through D, Myogenic constriction in response to increasing intraluminal pressure for cerebral arteries treated with TRPM4 sense (B) or antisense (C) ODNs. D, Summary myogenic tone data (mean ± SEM). *P<0.05 vs sense ODN-treated arteries. n=6 for both groups.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
Although the properties of cloned TRPM4 and TRPM5 are consistent with possible roles for these channels in the regulation of membrane potential and Ca2+ homeostasis of excitable cells, their function in smooth muscle has not previously been reported. The objective of this study was to determine whether these channels were present within the cerebral vasculature and how they influence arterial function. Our major findings were as follows: (1) a monovalent selective, Ca2+-dependent cation channel with unitary conductance of {approx}24 pS was present in cerebral artery smooth muscle cells; (2) TRPM4 message was present in cerebral artery myocytes, whereas mRNA encoding TRPM5 was not detected in these cells; (3) suppression of TRPM4 expression in isolated cerebral arteries decreased the frequency of observation of the {approx}24 pS channel and impaired pressure-induced smooth muscle depolarization; and (4) myogenic constriction of cerebral arteries was diminished by downregulation of TRPM4. Thus, our findings show that functional TRPM4 is present in VSM and suggest a critical role for this channel in the regulation of cerebral artery tone.

The biophysical characteristics of TRPM4 and TRPM5 are distinct from those of other TRPs. For example, other members of the TRP superfamily are nonselective or Ca2+-selective cation channels,12 whereas TRPM4 and TRPM5 exhibit specificity for monovalent cations.14,15 In addition, activation of TRPM4 and TRPM5 is dependent on intracellular [Ca2+],14,15,23,25 whereas other TRPs are either indifferent to or inhibited by intracellular Ca2+12. Cloned TRPM4 channels expressed in HEK cells are also voltage-dependent.14 Our data show that cation channels with unitary conductance, ionic selectivity, and Ca2+-dependence similar to those of TRPM4 and TRPM5 are present in cerebral artery myocytes. Unlike cloned TRPM4, these channels did not exhibit voltage dependence. Although the reason for differences in voltage sensitivity between expressed TRPM4 and the arterial smooth muscle cation channel are unclear, this may reflect differential tissue or species-specific properties of the channel, alternative splicing, or heteromultimerization of TRP channel proteins. Interestingly, a recent study demonstrates that cloned TRPM4 is not voltage dependent in the presence of decavanadate.28 This activity of decavanadate was found to be dependent on a cluster of positively charged amino acid residues in the C terminus of TRPM4. These findings suggest the possibility that the voltage dependence of TRPM4 may be modulated in native cells via this C-terminal domain. Despite the apparent differences in voltage dependence, our findings that message for TRPM4, but not TRPM5, was present in isolated cerebral artery myocytes and that the frequency of observation of the {approx}24 pS cation channel was reduced when TRPM4 expression was suppressed strongly suggests that that the Ca2+-dependent, monovalent-selective cation channel identified in cerebral artery smooth muscle cells is TRPM4.

Further experiments examined the functional role of TRPM4 in the cerebral vasculature. Deformation of the smooth muscle cell plasma membrane resulting in activation of mechanosensitive ion channels may contribute to depolarization associated with elevation of intraluminal pressure. In support of this possibility, a number of studies demonstrate stretch-activation of cation channels in smooth muscle cells.16–19 The unitary conductance for Na+ ions of these stretch-activated channels is {approx}25 pS, and the channels are inhibited by trivalent ions such as Gd3+. These properties are consistent with those of cloned TRPM4 and TRPM5 expressed in HEK cells.14,15 To test the hypothesis that the molecular identity of these previously described, stretch-activated channels is TRPM4, we successfully downregulated expression of this TRP protein in isolated cerebral arteries. We found that decreased TRPM4 expression is specifically associated with attenuated pressure-induced smooth muscle cell depolarization and myogenic constriction of these vessels. These findings demonstrate that TRPM4 is an important determinant of pressure-induced smooth muscle cell depolarization and vasoconstriction, suggesting a key role for this channel in the control of cerebral blood flow.

A previous study from our laboratory has demonstrated a critical role for TRPC6 in myogenic constriction of cerebral arteries,11 whereas the current study shows that TRPM4 is also very important in this response. These findings could be the result of nonselectivity of the antisense technology used to suppress TRP expression. For example, a recent study found that suppression of TRPM7 expression also downregulates TRPM2 in primary neuron cultures, suggesting transcriptional interdependency among TRP channels in these cells.29 To examine the possibility that a similar phenomenon was responsible for our observations, we evaluated the effects of TRPM4 antisense on TRPC6 expression and found that TRPC6 mRNA levels were unaltered by this treatment. We also examined the effects of TRPC6 antisense on TRPM4 expression and found TRPM4 levels to be unchanged when TRPC6 mRNA levels were decreased. These findings support the specificity of antisense procedures used for the current and previous11 studies and suggest that expression of both TRPM4 and TRPC6 is necessary for myogenic constriction of cerebral arteries. Given the diversity of biophysical properties and complex molecular biology of the TRP superfamily,12 a number of potential mechanisms for interaction between these two channels is possible. For example, activation of TRPM4 during increases in intraluminal pressure may occur as a result of TRPC6-dependent Ca2+ influx. Another possibility may be the formation of channels that comprised both TRPC6 and TRPM4 protein subunits. Previous studies have shown that heteromeric channels with novel characteristics can form when multiple TRPC proteins are coexpressed.30–32 Although heteromization of channels between different TRP families has not been reported, this could account for our observations. Of course, TRPC6 and TRPM4 channels could contribute to pressure-induced depolarization of cerebral VSM, independent of one another. The relative importance of the two channels in this response has not yet been determined, but studies of this type will provide important insights about the integrated functions and diversity of physiologic role of TRP channels in smooth muscle.

We report here that suppression of TRPM4 expression attenuates pressure-induced smooth muscle depolarization. This finding suggests that a TRPM4-dependent depolarizing current is activated by increased intravascular pressure, although the mechanism responsible for activation of this channel in smooth muscle cells is still unknown. Among TRP channels, Ca2+-dependence is unique to TRPM4 and TRPM5, suggesting that intracellular [Ca2+] may be an important regulatory stimulus under physiological conditions. However, considerable disagreement regarding the [Ca2+] required to open TRPM4 has been reported. Initially, Launay et al reported half-maximal Po of the cloned channel in whole cell experiments at intracellular [Ca2+] of {approx}0.4 µmol/L,15 whereas a study by Nilius et al reported that this value was 370 µmol/L for inside-out membrane patches.33 Our finding of half-maximal activation at {approx}200 µmol/L in cerebral artery smooth muscle cells is more in agreement with the latter study. The reason for the discrepancy in Ca2+ sensitivity of the channel is not known, but may be attributable to differences in experimental conditions used. Our findings suggest that the level of Ca2+ required to activate TRPM4 is greater than the physiological range (0.1 to 0.4 µmol/L) for global intracellular [Ca2+] normally encountered in smooth muscle cells. However, local [Ca2+] can exceed 10 µmol/L during transient Ca2+ events, such as Ca2+ sparks.34 Our findings show that this level of Ca2+ is sufficient to activate TRPM4 in smooth muscle cells. Transient Ca2+ events play a critical role in the regulation of K+ channel function in arterial smooth muscle.35 It is possible that such events also modulate TRPM4 activity, should the appropriate localization of TRPM4 channels and Ca2+ release sites be present in VSM.

Similar to a previous report using cardiac myocytes,21 we found that administration of a potent PKC activator increases the frequency of observation of a TRPM4-like channel in inside-out membrane patches from VSM cells. In addition, a PROSITE (http://us.expasy.org/prosite/) search of the mouse TRPM4 amino acid sequence identified several PKC activation sites on projected intracellular domains of the channel. These findings suggest that TRPM4 activity can be enhanced by PKC-dependent phosphorylation. Interestingly, an earlier study reports pressure-dependent increases in PKC translocation to the plasma membrane,36 whereas the current study demonstrates a critical role for TRPM4 in pressure-induced smooth muscle cell depolarization. These observations raise the possibility that pressure-dependent PKC activity contributes to activation of depolarizing currents mediated by TRPM4 in VSM cells. Although not directly addressed by the current study, this possibility is in agreement with a number of early reports demonstrating impaired myogenic constriction following PKC inhibition.37–39 Whereas evidence supporting Ca2+-independent pathways for PKC-induced vasoconstriction has been reported,40,41 other studies show that smooth muscle constriction induced by PKC activation is dependent on extracellular Ca2+ and can be blocked by antagonist of voltage-dependent Ca2+ channels.42–45 Furthermore, administration of PMA depolarizes both airway46 and cerebral artery47 smooth muscle, and this effect is blocked by PKC inhibition. Future investigations will examine the hypothesis that pressure-induced, PKC-dependent phosphorylation of TRPM4 constitutes a novel mechanism for myogenic depolarization and constriction of cerebral arteries.

In summary, the current study demonstrates an important role for TRPM4 in myogenic constriction of cerebral vessels. Considering the findings of our previous study show a similar role for TRPC6,11 we conclude that multiple TRP channels expressed by arterial smooth muscle participate in the regulation of cerebral blood flow.


*    Acknowledgments
 
This work was supported by National Heart, Lung, and Blood Institute grants F32HL075995 (to S.E.) and RO1HL58231 (to J.E.B.). We thank Johann Patlak for technical assistance, Drs Adrian Bonev and Thomas Heppner for advice on patch-clamp methodology, and Drs Kevin Thorneloe and Mark T. Nelson for critical comments on the manuscript.


*    Footnotes
 
Original received June 25, 2004; revision received September 24, 2004; accepted September 27, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol (London). 1902; 28: 220–231.[Free Full Text]
  2. Vinall PE, Simeone FA. Cerebral autoregulation: an in vitro study. Stroke. 1981; 12: 640–642.[Abstract/Free Full Text]
  3. Osol G, Halpern W. Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol. 1985; 249: H914–H921.[Medline] [Order article via Infotrieve]
  4. Hwa JJ, Bevan JA. Stretch-dependent (myogenic) tone in rabbit ear resistance arteries. Am J Physiol. 1986; 250: H87–H95.[Medline] [Order article via Infotrieve]
  5. Harder DR. Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res. 1984; 55: 197–202.[Abstract/Free Full Text]
  6. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol. 1998; 508 (Pt 1): 199–209.[Abstract/Free Full Text]
  7. Jones JV, Fitch W, MacKenzie ET, Strandgaard S, Harper AM. Lower limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res. 1976; 39: 555–557.[Abstract/Free Full Text]
  8. Kastrup J, Rorsgaard S, Parving HH, Lassen NA. Impaired autoregulation of cerebral blood flow in long-term type I (insulin-dependent) diabetic patients with nephropathy and retinopathy. Clin Physiol. 1986; 6: 549–559.[Medline] [Order article via Infotrieve]
  9. Agnoli A, Fieschi C, Bozzao L, Battistini N, Prencipe M. Autoregulation of cerebral blood flow. Studies during drug-induced hypertension in normal subjects and in patients with cerebral vascular diseases. Circulation. 1968; 38: 800–812.[Abstract/Free Full Text]
  10. Bruce DA, Langfitt TW, Miller JD, Schutz H, Vapalahti MP, Stanek A, Goldberg HI. Regional cerebral blood flow, intracranial pressure, and brain metabolism in comatose patients. J Neurosurg. 1973; 38: 131–144.[Medline] [Order article via Infotrieve]
  11. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res. 2002; 90: 248–250.[Abstract/Free Full Text]
  12. Clapham DE. TRP channels as cellular sensors. Nature. 2003; 426: 517–524.[CrossRef][Medline] [Order article via Infotrieve]
  13. Facemire CS, Mohler PJ, Arendshorst WJ. Expression and relative abundance of short transient receptor potential channels in the rat renal microcirculation. Am J Physiol Renal Physiol. 2004; 286: F546–F551.[Abstract/Free Full Text]
  14. Nilius B, Prenen J, Droogmans G, Voets T, Vennekens R, Freichel M, Wissenbach U, Flockerzi V. Voltage dependence of the Ca2+-activated cation channel TRPM4. J Biol Chem. 2003; 278: 30813–30820.[Abstract/Free Full Text]
  15. Launay P, Fleig A, Perraud AL, Scharenberg AM, Penner R, Kinet JP. TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell. 2002; 109: 397–407.[CrossRef][Medline] [Order article via Infotrieve]
  16. Park KS, Kim Y, Lee YH, Earm YE, Ho WK. Mechanosensitive cation channels in arterial smooth muscle cells are activated by diacylglycerol and inhibited by phospholipase C inhibitor. Circ Res. 2003; 93: 557–564.[Abstract/Free Full Text]
  17. Wu SN, Lin PH, Hsieh KS, Liu YC, Chiang HT. Behavior of nonselective cation channels and large-conductance Ca2+-activated K+ channels induced by dynamic changes in membrane stretch in cultured smooth muscle cells of human coronary artery. J Cardiovasc Electrophysiol. 2003; 14: 44–51.[CrossRef][Medline] [Order article via Infotrieve]
  18. Davis MJ, Donovitz JA, Hood JD. Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells. Am J Physiol. 1992; 262: C1083–C1088.[Medline] [Order article via Infotrieve]
  19. Ohya Y, Adachi N, Nakamura Y, Setoguchi M, Abe I, Fujishima M. Stretch-activated channels in arterial smooth muscle of genetic hypertensive rats. Hypertension. 1998; 31: 254–258.[Abstract/Free Full Text]
  20. Lesh RE, Somlyo AP, Owens GK, Somlyo AV. Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle. Circ Res. 1995; 77: 220–230.[Abstract/Free Full Text]
  21. Guinamard R, Chatelier A, Demion M, Potreau D, Patri S, Rahmati M, Bois P. Functional characterization of a Ca2+-activated non-selective cation channel in human atrial cardiomyocytes. J Physiol. 2004; 558: 75–83.[Abstract/Free Full Text]
  22. Fatt P, Ginsborg BL. The ionic requirements for the production of action potentials in crustacean muscle fibres. J Physiol. 1958; 142: 516–543.[Free Full Text]
  23. Liu D, Liman ER. Intracellular Ca2+ and the phospholipid PIP2 regulate the taste transduction ion channel TRPM5. Proc Natl Acad Sci U S A. 2003; 100: 15160–15165.[Abstract/Free Full Text]
  24. Perez CA, Huang L, Rong M, Kozak JA, Preuss AK, Zhang H, Max M, Margolskee RF. A transient receptor potential channel expressed in taste receptor cells. Nat Neurosci. 2002; 5: 1169–1176.[CrossRef][Medline] [Order article via Infotrieve]
  25. Hofmann T, Chubanov V, Gudermann T, Montell C. TRPM5 is a voltage-modulated and Ca(2+)-activated monovalent selective cation channel. Curr Biol. 2003; 13: 1153–1158.[CrossRef][Medline] [Order article via Infotrieve]
  26. Prawitt D, Monteilh-Zoller MK, Brixel L, Spangenberg C, Zabel B, Fleig A, Penner R. TRPM5 is a transient Ca2+-activated cation channel responding to rapid changes in [Ca2+]i. Proc Natl Acad Sci U S A. 2003; 100: 15166–15171.[Abstract/Free Full Text]
  27. Welsh DG, Brayden JE. Mechanisms of coronary artery depolarization by uridine triphosphate. Am J Physiol Heart Circ Physiol. 2001; 280: H2545–H2553.[Abstract/Free Full Text]
  28. Nilius B, Prenen J, Janssens A, Voets T, Droogmans G. Decavanadate modulates gating of TRPM4 cation channels. J Physiol. 2004.10.1113/jphysiol. 2004.070839.
  29. Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M. A key role for TRPM7 channels in anoxic neuronal death. Cell. 2003; 115: 863–877.[CrossRef][Medline] [Order article via Infotrieve]
  30. Goel M, Sinkins WG, Schilling WP. Selective association of TRPC channel subunits in rat brain synaptosomes. J Biol Chem. 2002; 277: 48303–48310.[Abstract/Free Full Text]
  31. Strubing C, Krapivinsky G, Krapivinsky L, Clapham DE. TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron. 2001; 29: 645–655.[CrossRef][Medline] [Order article via Infotrieve]
  32. Strubing C, Krapivinsky G, Krapivinsky L, Clapham DE. Formation of novel TRPC channels by complex subunit interactions in embryonic brain. J Biol Chem. 2003; 278: 39014–39019.[Abstract/Free Full Text]
  33. Nilius B, Prenen J, Voets T, Droogmans G. Intracellular nucleotides and polyamines inhibit the Ca(2+)-activated cation channel TRPM4b. Pflugers Arch. 2004; 448: 70–75.[CrossRef][Medline] [Order article via Infotrieve]
  34. Jaggar JH, Porter VA, Lederer WJ, Nelson MT. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol. 2000; 278: C235–C256.[Abstract/Free Full Text]
  35. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ. Relaxation of arterial smooth muscle by calcium sparks. Science. 1995; 270: 633–637.[Abstract/Free Full Text]
  36. Dessy C, Matsuda N, Hulvershorn J, Sougnez CL, Sellke FW, Morgan KG. Evidence for involvement of the PKC-alpha isoform in myogenic contractions of the coronary microcirculation. Am J Physiol Heart Circ Physiol. 2000; 279: H916–H923.[Abstract/Free Full Text]
  37. Osol G, Laher I, Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res. 1991; 68: 359–367.[Abstract/Free Full Text]
  38. Laher I, Bevan JA. Protein kinase C activation selectively augments a stretch-induced, calcium-dependent tone in vascular smooth muscle. J Pharmacol Exp Ther. 1987; 242: 566–572.[Abstract/Free Full Text]
  39. Hill MA, Falcone JC, Meininger GA. Evidence for protein kinase C involvement in arteriolar myogenic reactivity. Am J Physiol. 1990; 259: H1586–H1594.[Medline] [Order article via Infotrieve]
  40. Wesselman JP, Spaan JA, van der Meulen ET, VanBavel E. Role of protein kinase C in myogenic calcium-contraction coupling of rat cannulated mesenteric small arteries. Clin Exp Pharmacol Physiol. 2001; 28: 848–855.[CrossRef][Medline] [Order article via Infotrieve]
  41. Massett MP, Ungvari Z, Csiszar A, Kaley G, Koller A. Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol. 2002; 283: H2282–H2287.[Abstract/Free Full Text]
  42. Huang Y, Pai RK, Lau CW, Chan FL, Chen ZY, Yao XQ. Modulatory effect of protein kinase C activator on contractility of rat vas deferens. Pharmacology. 2001; 62: 2–9.[CrossRef][Medline] [Order article via Infotrieve]
  43. Lin MJ, Liu SH, Lin-Shiau SY. Phorbol ester-induced contractions of mouse detrusor muscle are inhibited by nifedipine. Naunyn Schmiedebergs Arch Pharmacol. 1998; 357: 553–557.[CrossRef][Medline] [Order article via Infotrieve]
  44. Masui H, Wakabayashi I. Extracellular Ca2+-dependent contractile action of phorbol 12,13-dibutyrate on gall bladder from guinea pig. Life Sci. 1997; 60: P L311–PL316.[CrossRef]
  45. Chiu PJ, Tetzloff G, Chatterjee M, Sybertz EJ. Phorbol 12,13-dibutyrate, an activator of protein kinase C, stimulates both contraction and Ca2+ fluxes in dog saphenous vein. Naunyn Schmiedebergs Arch Pharmacol. 1988; 338: 114–120.[Medline] [Order article via Infotrieve]
  46. Souhrada M, Souhrada JF. Sodium and calcium influx induced by phorbol esters in airway smooth muscle cells. Am Rev Respir Dis. 1989; 139: 927–932.[Medline] [Order article via Infotrieve]
  47. Slish DF, Welsh DG, Brayden JE. Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone. Am J Physiol Heart Circ Physiol. 2002; 283: H2196–H2201.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
StrokeHome page
T. E. Link, K. Murakami, M. Beem-Miller, B. I. Tranmer, and G. C. Wellman
Oxyhemoglobin-Induced Expression of R-Type Ca2+ Channels in Cerebral Arteries
Stroke, July 1, 2008; 39(7): 2122 - 2128.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Q. Xi, A. Adebiyi, G. Zhao, K. E. Chapman, C. M. Waters, A. Hassid, and J. H. Jaggar
IP3 Constricts Cerebral Arteries via IP3 Receptor-Mediated TRPC3 Channel Activation and Independently of Sarcoplasmic Reticulum Ca2+ Release
Circ. Res., May 9, 2008; 102(9): 1118 - 1126.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. Raina, S. R. Ella, and M. A. Hill
Decreased activity of the smooth muscle Na+/Ca2+ exchanger impairs arteriolar myogenic reactivity
J. Physiol., March 15, 2008; 586(6): 1669 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Touyz
Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1103 - H1118.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
H. A. Drummond, S. C. Grifoni, and N. L. Jernigan
A New Trick for an Old Dogma: ENaC Proteins as Mechanotransducers in Vascular Smooth Muscle
Physiology, February 1, 2008; 23(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schubert, D. Lidington, and S.-S. Bolz
The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction
Cardiovasc Res, January 1, 2008; 77(1): 8 - 18.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. A. Reading and J. E. Brayden
Central Role of TRPM4 Channels in Cerebral Blood Flow Regulation
Stroke, August 1, 2007; 38(8): 2322 - 2328.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Earley, S. V. Straub, and J. E. Brayden
Protein kinase C regulates vascular myogenic tone through activation of TRPM4
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2613 - H2622.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Hill and M. J. Davis
Coupling a change in intraluminal pressure to vascular smooth muscle depolarization: still stretching for an explanation
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2570 - H2572.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters
Transient Receptor Potential Cation Channels in Disease
Physiol Rev, January 1, 2007; 87(1): 165 - 217.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Numata, T. Shimizu, and Y. Okada
TRPM7 is a stretch- and swelling-activated cation channel involved in volume regulation in human epithelial cells
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C460 - C467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Ito, Y. P. R. Jarajapu, M. B Grant, and H. J Knot
Characteristics of myogenic tone in the rat ophthalmic artery
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H360 - H368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Zhang, R. Berra-Romani, M. J. Sinnegger-Brauns, J. Striessnig, M. P. Blaustein, and D. R. Matteson
Role of Cav1.2 L-type Ca2+ channels in vascular tone: effects of nifedipine and Mg2+
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H415 - H425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. L. Jernigan and H. A. Drummond
Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous beta and {gamma}ENaC
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1184 - F1191.
[Abstract] [Full Text]